1015 Capital Partners’s Clorox CLX Stock Holding History

1015 Capital Partners’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$202	–	607
2025 Q4	$202	Buy	+2	New	+$217	﹤0.01%	613

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

1015 Capital Partners's CLX Position: Q1 2026 in Review

1015 Capital Partners sold out of Clorox (CLX) in Q1 2026, closing a stake of 2 shares — an estimated $202 sold.

1015 Capital Partners first reported a position in CLX in Q4 2025 and held it in 1 quarter. The position peaked at $202 in Q4 2025. 1,086 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

1015 Capital Partners reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
1015 Capital Partners sold 2 Clorox shares in Q1 2026, an estimated $202.
1015 Capital Partners first reported a position in Clorox in Q4 2025 and held it in 1 quarter.
1015 Capital Partners's Clorox position peaked at $202 in Q4 2025.
1,086 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on 1015 Capital Partners's 13F filing for Q1 2026, filed 11 May 2026.